Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

被引：0
|
作者：
Kiyomi Ito
Koji Chiba
Masato Horikawa
Michi Ishigami
Naomi Mizuno
Jun Aoki
Yasumasa Gotoh
Takafumi Iwatsubo
Shin-ichi Kanamitsu
Motohiro Kato
Iichiro Kawahara
Kayoko Niinuma
Akiko Nishino
Norihito Sato
Yuko Tsukamoto
Kaoru Ueda
Tomoo Itoh
Yuichi Sugiyama
机构：
[1] Kitasato University,School of Pharmaceutical Sciences
[2] The University of Tokyo,Pharmacia
[3] The University of Tokyo,Nissan Chemical Industries, Ltd
[4] The University of Tokyo,Sankyo Co, Ltd
[5] The University of Tokyo,Mitsubishi
[6] The University of Tokyo,Tokyo Pharmaceuticals, Inc
[7] The University of Tokyo,Mitsui Pharmaceuticals Inc
[8] The University of Tokyo,Kissei Pharmaceutical Co, Ltd
[9] The University of Tokyo,Yamanouchi Pharmaceutical Co, Ltd
[10] The University of Tokyo,Otsuka Pharmaceutical Factory, Inc
[11] The University of Tokyo,Chugai Pharmaceutical Co, Ltd
[12] The University of Tokyo,Bayer Yakuhin Ltd
[13] The University of Tokyo,Daiichi Pharmaceutical Co, Ltd
[14] The University of Tokyo,Nippon Boehringer Ingelheim Co, Ltd
[15] The University of Tokyo,Shionogi & Co, Ltd
[16] The University of Tokyo,Nippon Roche KK
[17] The University of Tokyo,Teikoku Hormone Mfg Co, Ltd
来源：
AAPS PharmSci | / 4卷
关键词：
Drug interaction; metabolism; quantitative prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
When the metabolism of a drug is competitively or noncompetitively inhibited by another drug, the degree of in vivo interaction can be evaluated from the [I]u/Ki ratio, where [I]u is the unbound concentration around the enzyme and Ki is the inhibition constant of the inhibitor. In the present study, we evaluated the metabolic inhibition potential of drugs known to be inhibitors or substrates of cytochrome P450 by estimating their [I]u/Ki ratio using literature data.
引用
收藏
相关论文
共 50 条
  • [41] In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery
    Jain, Akhlesh K.
    Thareja, Suresh
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 524 - 539
  • [42] Which Value should be Used as the Lethal Concentration 50 (LC50) with Bacteria?
    Rath, Shakti
    Sahu, Mahesh C.
    Dubey, Debasmita
    Debata, Nagen K.
    Padhy, Rabindra N.
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2011, 3 (02) : 138 - 143
  • [43] Which value should be used as the lethal concentration 50 (LC50) with bacteria?
    Shakti Rath
    Mahesh C. Sahu
    Debasmita Dubey
    Nagen K. Debata
    Rabindra N. Padhy
    Interdisciplinary Sciences: Computational Life Sciences, 2011, 3 : 138 - 143
  • [44] Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances
    Obach, R. Scott
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (01) : 81 - 89
  • [45] Predicting drug interactions in vivo from experiments in vitro - Human studies with paclitaxel and ketoconazole
    JamisDow, CA
    Pearl, ML
    Watkins, PB
    Blake, DS
    Klecker, RW
    Collins, JM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (06): : 592 - 599
  • [46] COULD BIBLIOMETRIC DATA BE USED TO PREDICT CLINICAL SUCCESS OF A DRUG
    OSINGA, M
    JOURNAL OF DOCUMENTATION, 1977, 33 (03) : 239 - 240
  • [47] Polymedication and oral antitumour therapies- which drug interactions should be considered?
    Spani, Selina N.
    Mehra, Tarun
    Dongre, Kanchan
    Leuppi-Taegtmeyer, Anne B.
    THERAPEUTISCHE UMSCHAU, 2023, 80 (08)
  • [48] Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
    Iwatsubo, T
    Hirota, N
    Ooie, T
    Suzuki, H
    Shimada, N
    Chiba, K
    Ishizaki, T
    Green, CE
    Tyson, CA
    Sugiyama, Y
    PHARMACOLOGY & THERAPEUTICS, 1997, 73 (02) : 147 - 171
  • [49] Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
    Amin Rostami-Hodjegan
    Geoffrey T. Tucker
    Nature Reviews Drug Discovery, 2007, 6 : 140 - 148
  • [50] Scaling In Vivo Pharmacokinetics from In Vitro Metabolic Stability Data in Drug Discovery
    Klopf, Wendy
    Worboys, Philip
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2010, 13 (02) : 159 - 169
12345